Organizational predictors of pharmacological innovation adoption

The case of disulfiram

Hannah K. Knudsen, Paul M. Roman, Lori J. Ducharme, J Aaron Johnson

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The research-to-practice gap in substance abuse treatment, particularly with regard to pharmacological innovations, necessitates the consideration of organizational characteristics that facilitate the adoption of innovations. Using data from a nationally representative sample of 394 privately funded substance abuse treatment centers, this study examines variation in the adoption of disulfiram in terms of organizational structure, workforce professionalism, and treatment philosophy. Logistic regression results indicated that hospital-based centers were significantly more likely to use disulfiram than freestanding treatment programs. In addition, the percentage of counselors with master's degrees and the percentage of certified/licensed counselors were positively associated with the likelihood of disulfiram utilization. Treatment centers that emphasized confrontational group therapy and spirituality were less likely to use disulfiram, while the adoption of disulfiram was more likely in centers that emphasized a medical model of addiction.

Original languageEnglish (US)
Pages (from-to)559-574
Number of pages16
JournalJournal of Drug Issues
Volume35
Issue number3
StatePublished - Jun 1 2005
Externally publishedYes

Fingerprint

Disulfiram
counselor
substance abuse
Pharmacology
innovation
group therapy
organizational structure
spirituality
addiction
logistics
utilization
regression
Substance Abuse Treatment Centers
Spirituality
Therapeutics
Group Psychotherapy
Substance-Related Disorders
Logistic Models
Research
philosophy

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Health(social science)
  • Public Health, Environmental and Occupational Health
  • Psychiatry and Mental health

Cite this

Organizational predictors of pharmacological innovation adoption : The case of disulfiram. / Knudsen, Hannah K.; Roman, Paul M.; Ducharme, Lori J.; Johnson, J Aaron.

In: Journal of Drug Issues, Vol. 35, No. 3, 01.06.2005, p. 559-574.

Research output: Contribution to journalArticle

Knudsen, Hannah K. ; Roman, Paul M. ; Ducharme, Lori J. ; Johnson, J Aaron. / Organizational predictors of pharmacological innovation adoption : The case of disulfiram. In: Journal of Drug Issues. 2005 ; Vol. 35, No. 3. pp. 559-574.
@article{6755f6c59b2a4a668f75d999bf19dd69,
title = "Organizational predictors of pharmacological innovation adoption: The case of disulfiram",
abstract = "The research-to-practice gap in substance abuse treatment, particularly with regard to pharmacological innovations, necessitates the consideration of organizational characteristics that facilitate the adoption of innovations. Using data from a nationally representative sample of 394 privately funded substance abuse treatment centers, this study examines variation in the adoption of disulfiram in terms of organizational structure, workforce professionalism, and treatment philosophy. Logistic regression results indicated that hospital-based centers were significantly more likely to use disulfiram than freestanding treatment programs. In addition, the percentage of counselors with master's degrees and the percentage of certified/licensed counselors were positively associated with the likelihood of disulfiram utilization. Treatment centers that emphasized confrontational group therapy and spirituality were less likely to use disulfiram, while the adoption of disulfiram was more likely in centers that emphasized a medical model of addiction.",
author = "Knudsen, {Hannah K.} and Roman, {Paul M.} and Ducharme, {Lori J.} and Johnson, {J Aaron}",
year = "2005",
month = "6",
day = "1",
language = "English (US)",
volume = "35",
pages = "559--574",
journal = "Journal of Drug Issues",
issn = "0022-0426",
publisher = "Journal of Drug Issues Inc.",
number = "3",

}

TY - JOUR

T1 - Organizational predictors of pharmacological innovation adoption

T2 - The case of disulfiram

AU - Knudsen, Hannah K.

AU - Roman, Paul M.

AU - Ducharme, Lori J.

AU - Johnson, J Aaron

PY - 2005/6/1

Y1 - 2005/6/1

N2 - The research-to-practice gap in substance abuse treatment, particularly with regard to pharmacological innovations, necessitates the consideration of organizational characteristics that facilitate the adoption of innovations. Using data from a nationally representative sample of 394 privately funded substance abuse treatment centers, this study examines variation in the adoption of disulfiram in terms of organizational structure, workforce professionalism, and treatment philosophy. Logistic regression results indicated that hospital-based centers were significantly more likely to use disulfiram than freestanding treatment programs. In addition, the percentage of counselors with master's degrees and the percentage of certified/licensed counselors were positively associated with the likelihood of disulfiram utilization. Treatment centers that emphasized confrontational group therapy and spirituality were less likely to use disulfiram, while the adoption of disulfiram was more likely in centers that emphasized a medical model of addiction.

AB - The research-to-practice gap in substance abuse treatment, particularly with regard to pharmacological innovations, necessitates the consideration of organizational characteristics that facilitate the adoption of innovations. Using data from a nationally representative sample of 394 privately funded substance abuse treatment centers, this study examines variation in the adoption of disulfiram in terms of organizational structure, workforce professionalism, and treatment philosophy. Logistic regression results indicated that hospital-based centers were significantly more likely to use disulfiram than freestanding treatment programs. In addition, the percentage of counselors with master's degrees and the percentage of certified/licensed counselors were positively associated with the likelihood of disulfiram utilization. Treatment centers that emphasized confrontational group therapy and spirituality were less likely to use disulfiram, while the adoption of disulfiram was more likely in centers that emphasized a medical model of addiction.

UR - http://www.scopus.com/inward/record.url?scp=25844495789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25844495789&partnerID=8YFLogxK

M3 - Article

VL - 35

SP - 559

EP - 574

JO - Journal of Drug Issues

JF - Journal of Drug Issues

SN - 0022-0426

IS - 3

ER -